PMC4247313_01
Postoperative immunological pathology findings confirmed the lesion to be non-small cell lung cancer (adenocarcinoma). (A) Hematoxylin and eosin staining. (B-D) Immunological images showing the lesion to be (B) thyroid transcription factor 1-positive, (C) cytokeratin (CK) 88-positive and (D) CK-positive. All images: Magnification, x200.
ETM-09-01-0117-g00.jpg
PMC4247313_01_ETM-09-01-0117-g00.jpg
f1-etm-09-01-0117
The primary site was the lung with staging of T1N0M1. The lesion was confirmed to be non-small cell lung cancer (adenocarcinoma) with immunological pathology (Fig. 1).
(A and B) PET-CT scan showed an abnormal mass at the level of T9 and the left upper lobe of the lung. (C and D) Twenty-four months after treatment, PET-CT scan showed inactivation of the neoplasm in the left upper lobe and T9 vertebra and (C) a decrease in the left upper lobe mass in the short axis. PET-CT, positron emission tomography-computed tomography.
ETM-09-01-0117-g01.jpg
PMC4247313_01_ETM-09-01-0117-g01.jpg
f2-etm-09-01-0117
T9 vertebra (Fig. 2). This patient continues to be monitored through follow-up appointments.